A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs https://www.biorxiv.org/content/10.1101/2023.01.31.526400v1?med=mas
A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs https://www.biorxiv.org/content/10.1101/2023.01.31.526400v1?med=mas